Rapid and Efficient PCR Cleanup Filters
Agency: Department of Health and Human Services
Agency Tracking Number: RR024968
Phase: Phase I
Awards Year: 2008
Solicitation Year: 2008
Solicitation Topic Code: N/A
Solicitation Number: PHS2007-2
Small Business Information
DIFFINITY GENOMICS, INC.
DIFFINITY GENOMICS, INC., 150 LUCIUS GORDON DR, WEST HENRIETTA, NY, 14586
HUBZone Owned: Y
Woman Owned: Y
Socially and Economically Disadvantaged: Y
Phone: () -
Phone: (585) 273-4725
AbstractDESCRIPTION (provided by applicant): Analysis of DNA is important in many applications including forensics, agriculture, pathogen detection, diagnostic genetic testing and biomedical research. For the vast majority of genomic DNA analysis, chemical amplif ication methods such as polymerase chain reaction (PCR) amplification of a target sequence are used to increase the amount of the genetic fragment under study so that the sensitivity of common analytical methods is adequate. PCR, however, is only an early step for some important genomic assays such as capillary sequencing, MALDI-TOF based genotyping, microarray spotting, restriction analysis and cloning. For these, clean up of the PCR product is generally required, specifically to remove unamplified prime rs, excess nucleotides (dNTP) and additional organic components other than the desired amplicons. Cleanup products and protocols on the market are a significant contribution to the time, cost and labor involved in DNA analysis. They also exhibit poor recov ery of DNA for relatively short amplicons (lt 300 base pairs) as are preferred for speed of PCR and for a variety of applications such as multiplex PCR and handling of damaged DNA or RNA. Diffinity Genomics has licensed technology developed in the lab of the PI at the University of Rochester that is promising for single-step, 5 minute clean up of PCR product with high throughput for amplicons and efficient removal of primers and dNTP. The method has particular promise for the case of short amplicons cited above. The separation process exploits the recent finding that gold nanoparticles immobilized on high surface area substrates can selectively adsorb short, singlestranded DNA. Our goal is to take this observation and to produce a commercializable pr ototype kit suitable for the applications enumerated above. We will quantify the throughput of amplicons, primers and dNTP. Specific improvements to the form factor of the filter and surface attachment chemistry used to immobilize the gold nanopart icles will be evaluated for their effectiveness in increasing amplicon throughput and decreasing primer and dNTP throughput. We plan to increase surface area of silica beads utilized in the filters and the loading of gold nanoparticles in order to make the filters faster and longer lasting. We also propose to investigate uncharged mercaptosilane and negatively charged mixed monolayer coatings of the silica beads to reduce loss of amplicons in the filter. Improved recovery of the desired amplified DNA by mec hanical removal of the beads will also be implemented. Finally, we have arranged for beta testing of the filter prototypes by prospective customers. Individual genetics will increasingly be used both to prescribe therapeutic courses and to develop personalized drugs so that screening and sequencing DNA are very important to medical research and diagnosis. Polymerase chain reaction (PCR) products are routinely used in DNA analysis but require lengthy and cumbersome cleanup prior to sequencing. We pro pose to commercialize filters that improve recovery of short DNA segments from PCR products as as reduce the time, cost and labor associated with the cleanup procedure.
* information listed above is at the time of submission.